Salivary Gland Cancer Clinical Trials
There are over 600 live clinical trials for cancer in the UK today. Let us help you find the right trial for you.
RareCan is the only organisation in the UK that specialises in finding clinical trials for patients with rare cancer.
Please fill in the form to get started.
RareCan has over 10 members with salivary gland cancer
RareCan has over 50 members with salivary gland cancer
Prefer to do things by phone?
If you’d prefer to register by telephone, you can request a call-back by giving us your name and phone number below.
What is RareCan?
RareCan is a range of products and services that help you:
- Understand clinical trials and when they might an option for you
- Find trials that might be suitable for you now or in the future
- Get more detailed analysis of your tumour genetics to help identify potentially suitable clinical trials
- Understand genetics reports you have already had produced elsewhere and use them to find UK clinical trials
Book a free discovery call to find out if joining RareCan is right for you.
RareCan: Clinical Trial Service
£150 per year
- 1-2-1 telephone and email support from our experienced team
- A personalised report on potentially suitable clinical trials
- Updates to the report as new trials start or your situation changes
- Support to understand and discuss the report with your clinical team
RareCan: Insight
Price varies
- A range of high-precision multi-biomarker tests from blood or tissue samples that provide a detailed genomic profile of your tumour genetics
- A summary produced from an existing genetic report such as Guardent 360 or Foundation One to help you and your clinical team understand and use your existing report
Summary of Salivary Gland Cancer
What is Salivary Gland Cancer?
Salivary gland cancer is a rare type of head and neck cancer that begins in one of the salivary glands. There are three major pairs of salivary glands: the parotid glands (located just in front of the ears), the submandibular glands (under the jaw), and the sublingual glands (under the tongue). Most salivary gland tumours are benign, but some can be cancerous. The most common type of salivary gland cancer is mucoepidermoid carcinoma, followed by adenoid cystic carcinoma and acinic cell carcinoma.
How rare is it?
Salivary gland cancer is uncommon, with around 720 new cases diagnosed in the UK each year. It is slightly more common in men than in women. The majority of salivary gland tumours are benign, but a small percentage are malignant.
Who does it affect?
Salivary gland cancer can occur at any age but is most commonly diagnosed in people over the age of 60. Symptoms may include a painless lump or swelling in the jaw, mouth, cheek, or neck, numbness in part of the face, facial drooping, pain in the area of the lump, problems swallowing, or difficulty opening the mouth fully. Early diagnosis and treatment are crucial for better outcomes.
RareCan has over 3,000 members, here’s what some of them say.
The voices and experiences from our RareCan members, shared to help others on their own cancer journey.
“I joined RareCan to support research into my extremely rare and highly aggressive subtype of uterine cancer.”
— Lindy
RareCan Member
“I joined RareCan to get action and support and research on rare cancers”
— Steve
RareCan Member
“I joined RareCan because they have the solution to the challenges faced within rare cancer research.”
— Dave
RareCan Member
“I joined RareCan as it may help other people in the future.”
— Wayne
RareCan Member
“If my husband was alive today, he would encourage people to take part in research as you never know if you will ever need it in the future.”